Dear Editor, Given the widespread vaccination of the population with the novel mRNA vaccines against COVID-19, it is of utmost importance to identify any possible adverse effects they may have. In clinical trials with the BNT162b2 COVID-19 mRNA vaccine (Pfizer-ΒioNTech), adverse effects included mostly injection-site reactions, fatigue and headache. 1 Herein, we report a case of vitiligo following vaccination with the BNT162b2 COVID-19 mRNA vaccine (Pfizer/ BioNTech).A 69-year-old male presented with white macules on his face, abdomen, back, and upper and lower limbs that covered approximately 20% of his total body surface area (Figure 1). The lesions had appeared several months before his presentation, 3 days after his second dose of the BNT162b2 COVID-19 mRNA vaccine (Pfizer/BioNTech). The patient reported that the lesions appeared initially on the dorsal area of his hands, progressed to the rest of his body the following month and since then they had remained stable. There was no progression
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.